Scarica l'app Stockscreener
156.45
3.84%
5.79
Dopo l'orario di chiusura:
156.73
0.28
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Merck Co Inc Borsa (MRK) Ultime notizie
The Goldman Sachs Group Forecasts Strong Price Appreciation for Merck & Co., Inc. (NYSE:MRK) Stock - MarketBeat
Strong Merck stock trades close to its 52-week high as analysts lift targets after melanoma trial wi - Ad-hoc-news.de
Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement - TradingKey
Moderna and Merck cancer vaccine success paves way for future - EMJ
TCW Group Inc. Sells 16,921 Shares of Merck & Co., Inc. $MRK - MarketBeat
Summit Global Investments Sells 15,559 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Commonwealth Retirement Investments LLC - MarketBeat
Crew Capital Management Ltd Acquires 7,742 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Acumen Wealth Advisors LLC - MarketBeat
RBC Capital Downgrades Merck & Co as Profit-Taking Sets In - marketscreener.com
Merck & Co. stock hits record high as cancer vaccine data lifts 2026 outlook - Ad-hoc-news.de
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $170.00 - MarketBeat
Merck Raises the Stakes for Pfizer's Cancer Vaccine AmbitionsModerna (NASDAQ:MRNA), Merck & Co (NYSE:M - Benzinga
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $175.00 - MarketBeat
Merck & Co. stock extends double-digit August rally as analyst calls and cancer vaccine data reshape - Ad-hoc-news.de
RBC Capital downgrades Merck & Co as profit-taking hits the stock - marketscreener.com
Merck upgraded at Morgan Stanley after cancer trial win; RBC downgrades - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Downgraded to "Sector Perform" Rating by Royal Bank Of Canada - MarketBeat
This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Elon Musk Backs mRNA As Moderna's Stock Soars on Cancer Vaccine WinModerna (NASDAQ:MRNA) - Benzinga
Merck & Co., Inc. (NYSE:MRK) Raised to Overweight at Morgan Stanley - MarketBeat
Goldman Sachs Adjusts Price Target on Merck & Co. to $160 From $140, Keeps Buy Rating - Moomoo
Merck & Co., Inc. (NYSE:MRK) Stock Rating Lowered by Jefferies Financial Group - MarketBeat
Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116 - marketscreener.com
Jennison Associates LLC Has $350.67 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Trimmed by Hohimer Wealth Management LLC - MarketBeat
Hodges Capital Management Inc. Sells 8,148 Shares of Merck & Co., Inc. $MRK - MarketBeat
Massachusetts Financial Services Co. MA Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. stock jumps to record high as cancer vaccine data eases Keytruda risk - Ad-hoc-news.de
MERCK & CO INC : JEFFERIES RAISES TARGET PRICE TO $175 FROM $152 - Moomoo
Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today? - TradingView
Healthcare Stocks After Hours: Moderna, Merck Cool Following Cancer Trial GainsPfizer (NYSE:PFE), Mode - Benzinga
Merck & Co Inc : Argus Research Raises Ta - Moomoo
MRNA, BULL, BMNR, MSTR, MRK: 5 Trending Stocks TodayModerna (NASDAQ:MRNA) - Benzinga
Shareholders that lost money on Merck & Co., Inc.(MRK) should con - The National Law Review
Why Moderna Stock Skyrocketed Today - The Motley Fool
Moderna and Merck: Intismeran's Positive Phase 3 Readout Confirms mRNA Potential in Oncology - Morningstar
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy? - Finviz
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Merck & Co Inc (MRK) Stock Up 12.6% but GF Value Says Overvalued -- GF Score: 72/100 - GuruFocus
Merck's Large Late-Stage Pipeline Is Building Solid Defense Against Keytruda's Patent Cliff - Morningstar
Pfizer Stock Rises Wednesday: What's Going On? - Benzinga
Stock Traders Buy High Volume of Merck & Co., Inc. Call Options (NYSE:MRK) - MarketBeat
Huge Unusual Put Options Volume in MerckIs MRK Stock Overvalued? - Barchart.com
MERCK CO INC - Financial Post
Merck Soars On Cancer Vaccine Trial Win With Moderna, More Upside Ahead (NYSE:MRK) - Seeking Alpha
Merck: Why Consolidation Looks Like The Next Move (Rating Downgrade) (NYSE:MRK) - Seeking Alpha
Merck stock hits a new 52-week high on melanoma data - Ad-hoc-news.de
Moderna's Cancer Vaccine Win Is Merck's Story Too - Benzinga
Tempus AI Soars as Merck-Moderna Cancer Trial Validates Personalis Acquisition - Benzinga
VIEW Moderna-Merck melanoma vaccine data boosts outlook, but analysts await full results - Reuters
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday - Benzinga
Merck & Co Inc Stock (MRK) Opened Up by 8.82% on Aug 19: Key Drivers Unveiled - tradingkey.com
Moderna, Merck surge on positive trial results for melanoma vaccine - Sharecast.com
Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar - Benzinga
Merck, Moderna say melanoma vaccine meets goals in large trial - Reuters
Narwhal Capital Management Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Vest Financial LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by D.A. Davidson & CO. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Sets New 12-Month HighHere's What Happened - MarketBeat
Benjamin Edwards Inc. Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck stock holds firm as Q2 sales hit $16.61 billion - AD HOC NEWS
Merck stock hits a record high. Investors track valuation and growth - AD HOC NEWS
Cisco, Merck, Cheniere Energy And More: CNBC’s ‘Final Trades’ - Benzinga
Merck & Co. Inc. Invests $9.04 Billion in Sutro Biopharma, Inc. $STRO - MarketBeat
Merck & Co. Inc. Takes Position in Kymera Therapeutics, Inc. $KYMR - MarketBeat
93,414 Shares in Viridian Therapeutics, Inc. $VRDN Purchased by Merck & Co. Inc. - MarketBeat
What Is Driving Interest in Merck & Co. (NYSE:MRK) as Pharmaceutical Deals Keep Flowing? - Kalkine Media
Munich Reinsurance Co Stock Corp in Munich Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Mizuho Markets Cayman LP Invests $960,000 in Merck & Co., Inc. $MRK - MarketBeat
Resilient Merck stock holds close to a 12-month high on oncology strength - AD HOC NEWS
Merck (NYSE: MRK): What Could Drive Its Next Phase? - Kalkine Media
Resilient Merck stock trades at a 12-month high as fresh FDA approvals and Q2 2026 growth support th - AD HOC NEWS
Merck & Company, Inc. (MRK) Investor Outlook: Exploring Growth with a Robust Pipeline and Strategic Collaborations - DirectorsTalk Interviews
Merck & Co., Inc. (NYSE:MRK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
ABN Amro Investment Solutions Has $39.71 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck stock trades close to its 12-month high as Q2 2026 growth and Keytruda momentum support the ou - AD HOC NEWS
1.24%
0.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):